InsiderTrades

Form 4 for ZBIO Zenas BioPharma, Inc.

Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0001104659-24-101030 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-09-18 2024-09-16 ZBIO Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% C - Cnv Deriv — +801.6K 801.6K New —
DM 2024-09-18 2024-09-16 ZBIO Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% C - Cnv Deriv — -6.96M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-16 C A 420,271 — 600,906 D — — (F1) On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
2 Common Common Stock 2024-09-16 C A 180,635 — 180,635 D — — (F1) On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
3 Common Common Stock 2024-09-16 C A 200,718 — 801,624 D — — (F1) On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
4 Derivative Series A Convertible Preferred Stock 2024-09-16 C D 1,568,480 — 0 D — · — to — 180,635 Common Stock (F1) On September 16, 2024, the shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
5 Derivative Series C Convertible Preferred Stock 2024-09-16 C D 1,742,858 — 0 D — · — to — 200,718 Common Stock (F3) On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
6 Derivative Series B Convertible Preferred Stock 2024-09-16 C D 3,649,263 — 0 D — · — to — 420,271 Common Stock (F2) On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.